These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6258506)

  • 21. [Short range action of inactivated hyperimmune human serum on the trophozoite of Entamoeba histolytica].
    Guerrero-Alcázar M; Ramírez-Espinosa ME; González SM; Sepúlveda B
    Arch Invest Med (Mex); 1972; 2():Suppl 2:311-8. PubMed ID: 4349093
    [No Abstract]   [Full Text] [Related]  

  • 22. A monoclonal antibody specific for a 40 kDa polypeptide recognizes pathogenic strains of Entamoeba histolytica.
    León G; Tovar R; Muñoz ML
    Arch Med Res; 1994; 25(2):223-8. PubMed ID: 7919818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Entamoeba histolytica proteolytic activity by human salivary IgA antibodies.
    Guerrero-Manríquez GG; Sánchez-Ibarra F; Avila EE
    APMIS; 1998 Nov; 106(11):1088-94. PubMed ID: 9890272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Entamoeba histolytica: cytopathogenicity, including serum effects on contact-dependent and toxin-induced lysis of hamster kidney cell monolayers.
    Bos HJ; Leijendekker WJ; van den Eijk AA
    Exp Parasitol; 1980 Dec; 50(3):342-57. PubMed ID: 6253314
    [No Abstract]   [Full Text] [Related]  

  • 25. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.
    Campos-Rodríguezp R; Jarillo-Luna A
    Parasite Immunol; 2005; 27(1-2):1-8. PubMed ID: 15813717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in morphology of phagosomes and kinetics of acidification and degradation in phagosomes between the pathogenic Entamoeba histolytica and the non-pathogenic Entamoeba dispar.
    Mitra BN; Yasuda T; Kobayashi S; Saito-Nakano Y; Nozaki T
    Cell Motil Cytoskeleton; 2005 Oct; 62(2):84-99. PubMed ID: 16106449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic differentiation with restriction patterns between pathogenic and non-pathogenic monoxenic Entamoeba histolytica].
    Crisóstomo Vázquez P; Jiménez Cardoso E
    Rev Invest Clin; 2000; 52(3):255-60. PubMed ID: 10953608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
    Lin JY; Seguin R; Keller K; Chadee K
    Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amebiasis: host-pathogen biology.
    Sepúlveda B
    Rev Infect Dis; 1982; 4(6):1247-53. PubMed ID: 6296964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Entamoeba histolytica: surface proteolytic activity and its relationship with in vitro virulence.
    Araiza-Orozco LM; Avila EE; Muñoz ML; Arias-Negrete S
    Folia Parasitol (Praha); 1999; 46(3):161-7. PubMed ID: 10553649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptomic comparison of two Entamoeba histolytica strains with defined virulence phenotypes identifies new virulence factor candidates and key differences in the expression patterns of cysteine proteases, lectin light chains, and calmodulin.
    Davis PH; Schulze J; Stanley SL
    Mol Biochem Parasitol; 2007 Jan; 151(1):118-28. PubMed ID: 17141337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Advances in research on virulence factors of Entamoeba histolytica].
    Chen Y; Cheng XJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Dec; 24(6):457-60. PubMed ID: 17366980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced pro-inflammatory chemokine/cytokine response triggered by pathogenic Entamoeba histolytica : basis of invasive disease.
    Sharma M; Vohra H; Bhasin D
    Parasitology; 2005 Dec; 131(Pt 6):783-96. PubMed ID: 16336732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunodulation of rat serum and mucosal antibody responses to Entamoeba histolytica trophozoites by beta-1,3-glucan and cholera toxin.
    Navarro-García F; Pedroso M; López-Revilla R
    Clin Immunol; 2000 Nov; 97(2):182-8. PubMed ID: 11027459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence of entamoeba histolytica strains from Bombay (India) to rats.
    Guirges SY
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(2):141-51. PubMed ID: 6288796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Entamoeba histolytica: molecular characterization of an aldose 1-epimerase (mutarotase).
    Villalobo E; Wender N; Mirelman D
    Exp Parasitol; 2005 Jul; 110(3):298-302. PubMed ID: 15869755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The killing of Entamoeba histolytica by activated human eosinophils.
    López-Osuna M; Arellano J; Giménez-Scherer JA; Kretschmer RR
    Arch Med Res; 1992; 23(2):143-5. PubMed ID: 1340278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic methods for differentiation of Entamoeba histolytica and Entamoeba dispar in carriers: performance and clinical implications in a non-endemic setting.
    Visser LG; Verweij JJ; Van Esbroeck M; Edeling WM; Clerinx J; Polderman AM
    Int J Med Microbiol; 2006 Oct; 296(6):397-403. PubMed ID: 16753339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Entamoeba sp. strain isolated from rhesus monkey is virulent but genetically different from Entamoeba histolytica.
    Tachibana H; Yanagi T; Pandey K; Cheng XJ; Kobayashi S; Sherchand JB; Kanbara H
    Mol Biochem Parasitol; 2007 Jun; 153(2):107-14. PubMed ID: 17403547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between Entamoeba histolytica and the immune system. I. Mitogenicity of Entamoeba histolytica extracts for human peripheral T lymphocytes.
    Diamantstein T; Klos M; Gold D; Hahn H
    J Immunol; 1981 Jun; 126(6):2084-6. PubMed ID: 6262406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.